about
Endothelial secreted factors suppress mitogen deprivation-induced autophagy and apoptosis in glioblastoma stem-like cells.Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside.The DNMT1/PCNA/UHRF1 disruption induces tumorigenesis characterized by similar genetic and epigenetic signatures.Control of glioma cell death and differentiation by PKM2-Oct4 interaction.Pharmacological targeting of apelin impairs glioblastoma growth.HB-EGF is associated with DNA damage and Mcl-1 turnover in human glioma cell lines treated by Temozolomide.Functional effects of diphosphomimetic mutations at cAbl-mediated phosphorylation sites on Rad51 recombinase activity.Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib.Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapyNKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma CellsGlyphosate Primes Mammary Cells for Tumorigenesis by Reprogramming the Epigenome in a TET3-Dependent MannerTumor cells hijack enteric glia to activate colon cancer stem cells and stimulate tumorigenesisThe vitamin K-dependent factor, protein S, regulates brain neural stem cell migration and phagocytic activities towards glioma cellsImpairing temozolomide resistance driven by glioma stem-like cells with adjuvant immunotherapy targeting O-acetyl GD2 gangliosideLow-Dose Pesticide Mixture Induces Accelerated Mesenchymal Stem Cell Aging In VitroCharacterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?miR-370-3p Is a Therapeutic Tool in Anti-glioblastoma Therapy but Is Not an Intratumoral or Cell-free Circulating Biomarker
P50
Q35135190-0AA6C66D-44F5-49C6-BD86-684D392F2EECQ37520179-B17C3891-2F7F-47F4-A30D-A3E69CF83199Q37642498-85C0CC50-D545-4979-B1F2-4A1B8E08AC9BQ39028792-073D8076-A98C-4FD8-803C-E9C81A418B2EQ47623927-0DECA0DE-F55B-428E-A9C6-0CF8BDD21AC0Q47712957-AB84B65D-86AD-4403-9DB5-83D879F4DAEDQ50964460-07680BBB-BC09-42F5-974E-82E179AEA3E3Q53743370-2B75ADAB-581C-47AE-A0D9-3A2B88035B2DQ61978393-9C4D2F60-39AC-4258-BC1E-9D9DC5B89C42Q90044403-A45D96CF-9159-47BE-B76B-EA9609236B56Q90705372-A8C3A0F8-8F99-4E10-B1C1-EA9A1581E1BEQ90989968-7D841C63-82BA-496C-8CE6-039CDB5A4133Q91560851-4C77BA05-4C2E-40E7-BD01-644F63CE41DDQ93038188-0B0D1913-E204-49E8-87DB-0DD3047FFF4CQ93049072-1A450890-82C5-4D92-BB97-81FB819B8E3EQ93369529-65F17583-977D-4EE7-B0CA-6CA3D230C814Q93370756-99EA8115-3865-4EA2-80BE-43067D129B80
P50
description
researcher
@en
wetenschapper
@nl
name
François M Vallette
@en
François M Vallette
@nl
type
label
François M Vallette
@en
François M Vallette
@nl
prefLabel
François M Vallette
@en
François M Vallette
@nl
P31
P496
0000-0002-3296-8572